TeleMAb Retrospective Cohort Study

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT07405294
Status
Active Not Recruiting

Conditions

  • Medication Abortion
  • Telemedicine

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Telemedicine Medication Abortion — OTHER
    Meeting with a clinician via video visit to determine if patient is eligible for medication abortion without pre-treatment ultrasound or laboratory testing. If eligible, the patient travels to clinic to pick up medications in person.

Study Details

The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.

Key Dates

Start date
Jun 12, 2023
Status verified
Feb 2026
Primary completion
Nov 15, 2025
Completion
Jul 31, 2026

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: Telemedicine Med Ab
    Patients who received medication abortion through the telemedicine medication abortion service during the study period.
  • Arm: In-person Med Ab
    Patients who received an in-person medication abortion at the clinic during the study period.

Primary Outcome Measure

Number of unscheduled follow-ups [ Time Frame: 3 months after initial encounter ]

Locations (1)

FacilityCityStateZIPSite coordinators
Columbia University Irving Medical CenterNew YorkNew York10032-3720-

Find similar trials in New York, NY

By research site
Columbia University Irving Medical Center· New York, NY

Related Studies